Simply Wall St.2d agobearish
SELLAS Life Sciences Group (SLS) Stock Could Be Fully Priced On Phase 3 Analysis TriggerNotícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.10d agobearish
SELLAS Life Sciences Group (SLS) Dropped, So What Is Behind The Latest Attention?Insider Monkey39d agobearish
Despite Heavy Hedge Fund Support, Why Sellas Life Sciences (SLS) Fell 16.6% in Q3Simply Wall St.39d agobearish
Can SELLAS Life Sciences (SLS) Turn Early CDK9 Pancreatic Data Into a Durable Oncology Edge?Simply Wall St.39d agobearish
SELLAS Life Sciences Group (SLS) Stock May Be Trading At A Premium On Fresh Pancreatic Cancer DataSimply Wall St.39d agobearish
SELLAS Life Sciences Group (SLS) Could Be Fully Priced After Fresh SLS009 Pancreatic DataSimply Wall St.67d agobearish
SELLAS Life Sciences Group (SLS) Lands 3 AACR Abstracts For SLS009 Pancreatic Cancer DataSimply Wall St.79d agobearish
Is SELLAS (SLS) Turning Sector Hype Into a Durable Cancer Vaccine Story Despite Ongoing Losses?Simply Wall St.79d agobearish
SELLAS Life Sciences Group (SLS) Shares Just Moved, So What Is Drawing Attention?Simply Wall St.80d agobearish
SELLAS Life Sciences Group (SLS) Stock Looks Stretched Despite Key AML Trial ProgressSimply Wall St.96d agobearish
SELLAS Life Sciences Group (SLS) Nears REGAL Analysis, Is The Stock Too Expensive?